儿童泌尿外科复杂下尿路重建术中的加速康复外科应用
PURSUE多中心前瞻性研究将153例ERAS患者与153例倾向匹配历史对照比较,评估20项ERAS方案依从性及结局。ERAS组方案依从性中位数从8项升至16项,住院时间从8.0天降至5.3天,术后阿片类药物使用减少74%,并发症率从72.5%降至60.1%,90天再就诊无差异。
要点
- ERAS方案依从性中位数从8项提升至16项(P<.001)。
- 住院时间中位数从8.0天降至5.3天(P<.001)。
- 并发症率从72.5%降至60.1%(P=.01),90天再就诊无差异。
核心结论
- ERAS在儿童泌尿外科复杂下尿路重建术中有效标准化围术期管理。
- ERAS与住院时间缩短、术后阿片类药物使用减少及并发症率降低相关。
研究设计与样本
- 多中心前瞻性研究,8家儿童医院于2017至2022年实施ERAS方案。
- 153例ERAS患者与153例倾向匹配历史对照比较,年龄中位数分别为10.2岁和10.4岁(P=.47)。
- 纳入4至24岁接受可控通道建立、膀胱扩大和/或膀胱颈手术患者,排除未管理的神经源性肠功能障碍者。
主要发现
- ERAS组方案依从性中位数从8项升至16项(P<.001)。
- 住院时间中位数从8.0天降至5.3天(P<.001)。
- 术后阿片类药物使用减少74%,最大疼痛评分未增加。
- 并发症率从72.5%降至60.1%(P=.01)。
- 90天急诊就诊、再入院或再手术无差异。
关键数值与推荐
- ERAS方案包含20项基于证据的术前、术中及术后要素,作为标准治疗实施。
- 主要结局为ERAS方案依从性,次要结局包括住院时间、阿片类药物使用、疼痛评分、90天并发症及90天再就诊平衡指标。
临床怎么用
- 在儿童泌尿外科复杂下尿路重建术中可实施ERAS方案以标准化围术期管理。
- 实施ERAS有助于缩短住院时间、减少术后阿片类药物使用并降低并发症率,且不增加90天再就诊。
局限性
- 研究采用历史对照而非同期随机对照,可能存在时代偏倚。
- 随访时间最短1年,长期结局未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Enhanced recovery after surgery (ERAS) is a multidisciplinary framework to standardize perioperative care. Pediatric Urology Recovery After Surgery Endeavor (PURSUE) is a multicenter study of ERAS in children undergoing complex lower urinary tract reconstruction. Use of ERAS in children is still relatively uncommon and outcomes are not well understood. OBJECTIVE: To attempt to achieve 70% or more ERAS adherence while reducing length of stay and opioid use without an increase in complications or other balancing measures. DESIGN, SETTING, AND PARTICIPANTS: This study prospectively enrolled patients who were propensity matched to recent historical controls prior to ERAS implementation and outcomes were compared. From 2017 through 2022, 8 pediatric hospitals implemented ERAS for pediatric patients undergoing catheterizable channel creation, bladder augmentation, and/or bladder neck procedures. Patients aged 4 to 24 years undergoing these operations were prospectively enrolled in the study. Patients with unmanaged neurogenic bowel were excluded. Patients who underwent these operations in the 5 years prior to protocol implementation at each center were used as a comparator group. These data were analyzed from July 2022 to April 2025. INTERVENTION: ERAS protocol encompassing 20 evidence-based preoperative, intraoperative, and postoperative elements was designed and implemented as standard of care. Patients were followed up postoperatively for a minimum of 1 year. MAIN OUTCOMES AND MEASURES: The primary outcome was compliance with the ERAS protocol. Secondary outcomes included length of stay, opioid usage, pain scores, 90-day complications, and 90-day balancing measures of return to hospital. RESULTS: A total of 153 ERAS patients and 153 historical controls were matched with a median (IQR) age of 10.2 (7.6-13.7) and 10.4 (8.0-14.6) years, respectively (P = .47). Median protocol adherence increased from 8 to 16 measures between historical and ERAS cohorts (P < .001). Median length of stay decreased from 8.0 to 5.3 days (P < .001). Postoperative opioid use decreased 74% without an increase in maximum pain scores. Complication rates decreased from 72.5% to 60.1% (P = .01) with no differences in 90-day emergency department visits, readmissions, or reoperations. CONCLUSIONS AND RELEVANCE: In this study, ERAS was highly effective at standardizing perioperative care in pediatric urology patients undergoing complex lower urinary tract reconstruction. ERAS was associated with better outcomes of reduced length of stay, lower postoperative opioid use, and lower complication rates.
引用
- Rove KO, Strine AC, Chu DI, et al. Enhanced Recovery After Surgery in Pediatric Urology Patients Undergoing Complex Lower Urinary Tract Reconstruction. JAMA Surg. 2026. PMID: 42647038. doi:10.1001/jamasurg.2026.3703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。